NEWSLETTER
Zvekubvunza nezve zvigadzirwa zvedu kana mutengo runyorwa, ndapota siya email yako kwatiri uye isu tichabatana mukati memaawa makumi maviri nemana.
KUBVUNZA ZVINOMamiriro ekufambisa
Inogona kunge iri mutembiricha yakajairika
Kurudzira nzira yekutumira
Nemhepo By land By gungwa
Mamiriro ekuchengetedza:
Ramba uri munzvimbo ine rima, Inert atmosphere, Tembiricha yemumba
Sherufu hupenyu
Anenge makore maviri
Minimum Order Qty:
1kg (kutaurirana)
Certification:COA, nzvimbo yakanyungudika, SpecificRotation [α]D20
Isu tichatumira chero data yaunoda.Iwe unogona kuona iyo data kare sereferensi.
Kune zvigadzirwa zvakasarudzika, tinotumira data nyowani mushure mekunge vabuda.
N2-Boc-L-lysine;
N-alpha-Acetyl-Nεn-Boc-L-lysine;
(2S) -6-amino-2-(tert-butoxycarbonylamino)hexanoicacid;
(2S) -6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoicacid;
(S) -2-[(tert-Butyloxycarbonyl)amino]-6-aminohexanoicacid
Vanowanzo shandiswa kurongedza hupfu.Zvinoenderana nezvinodiwa nevatengi.Kuti zvirambe zvakanaka kusvika kwaunoenda.Tichavhara mabhodhoro epurasitiki nematepi machena epurasitiki pane gap rezvivharo.
Kurongedza kwekunze kwakaoma.Uye zvakaoma kucheka uye kukuvadza.Inogona kudzivirira zvigadzirwa zvako zvakakwana.Tichayambuka tepi yepurasitiki kunze kugadzirisa chikamu chese.Uye kana zvichidikanwa, isu tichavabata chibharo nekutambanudza firimu kunze.
13734-28-6 Boc-Lys-OH, inozivikanwawo seN-alpha-tert-butoxycarbonyl-L-lysine, inonzi biochemical reagent iyo inogona kushandiswa sechivako chekuvaka muhupenyu hwakasiyana-siyana hwekutsvaga tsvakurudzo.
Kunyanya, 13734-28-6 Boc-Lys-OH inobatanidzwa mukugadzirisa kwe thymic peptides yakadai se β4, βg, uye β6 zvidimbu.Iyo inosimudzira E-rosette kugadzira kugona uye inoita basa mune lupus nephritis modhi.Pamusoro pezvo, Boc-Lys-OH inoshandiswa mukubatanidza kweBoc-Lyz-OCH3 uye inoshanda seyakagadzirwa reagent ye peptide-based thrombin inhibitors.
13734-28-6 Boc-Lys-OH ndeimwe yeTirzepatide yepakati.
Tirzepatide inova glucagon-like peptide-1 receptor (GLP-1) uye glucose-inotenderera insulinotropic polypeptide (GIP) dual receptor agonist, inotungamirirwa kamwe chete pavhiki.GLP-1 uye GIP zvose zviri enteroglucagon, peptides yakavanzwa nemucosa yemudumbu. turakiti remuviri wemunhu, uye yekare inogona kusunga kune receptor pane pancreatic islet masero uye inokurudzira kuvharidzirwa kwe insulini, nokudaro ichiita glucose-kuderedza migumisiro, uye inononokawo kubvisa gastric uye kudzvinyirira chido, nokudaro kudzora uremu hwemuviri;nepo iyo yekupedzisira ine basa rekudzivisa gastric acid, inokurudzira kusunungurwa kwe insulini, uye inhibiting gastric motility uye kubvisa, izvo zvinogona kuwedzera GLP-1.Iyo yekare inogona kusunga kune zvinogamuchirwa papancreatic islet masero uye inokurudzira insulin secretion, nokudaro inogadzira hypoglycemic effect, pamwe nekunonoka kubvisa gastric uye kudzvinyirira chido, nokudaro kudzora uremu hwemuviri;nepo iyo yekupedzisira ine mabasa ekudzivisa gastric acid uye pepsin secretion, inosimudzira insulin kuburitswa, inhibiting gastric peristalsis uye kubuda, uye inogona kuwedzera basa reGLP-1 agonist.
Lys(Fmoc).HCl | Cbz-L-Ls(Fmoc)-OH | Boc-Ls(Cbz).DCHA |
Boc-Ls(tfa)-OH | Boc-Ls(Cbz)-Ol | Boc-Ls(AC)-OH |
Boc-L-Ls(Cbz)-OH | Boc-L-Ls(Boc)-OSu | Boc-L-Ls(Boc)-OH·DCHA |
Boc-Ls(Boc)-OH | Boc-D-Ls(Boc)-OH | Boc-L-Ls(Fmoc)-OH |
Fmoc-L-Ls(tfa)-OH | Fmoc-D-Ls(Boc)-OH | Fmoc-L-Ls(Boc)-OH |
Cbz-Ls(Boc)-ome-OH | Cbz-Ls(Boc)-Otbu-OH | Cbz-L-Ls(BOC)-OH |
1. Mafekitari edu ndeye ISO 9001, ISO 14001 uye ISO 45001 yakasimbiswa.
2. Professional online service timu, chero email kana meseji ichapindurwa mukati meawa makumi maviri nemana.
3. Tine boka rakasimba rekupa vatengi vedu basa remwoyo wose nguva dzose.
4. Tinoomerera kuti vatengi vedu vauye pakutanga uye vashandi vedu vanoshuva kufara.
5. Ita kuti kunaka kuve chinhu chekutanga kufunga.